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Objective: The notion that cerebellar pathology may contribute to cognitive impairment
in ALS, especially in patients with C9orf72 repeated expansion, has been inconsistently
reported. This study aimed exploring the relationship between cerebellar involvement,
cognitive impairment and C9orf72 repeated expansion of patients with ALS.
Methods: Quantitative in vivo assessment of cerebellar lobules has been investigated
in 66 non-demented patients with ALS and 28 healthy controls (HCs). Pathologic
C9orf72 repeated expansion was found in 13 patients. Mild cognitive and/or behavioral
impairment was diagnosed in 22 C9orf72 negative ALS patients. Measures of cortical
volume (CV) and cortical thickness (CT) of cerebellar lobules of all participants were used
for Principal Component Analysis (PCA) to identify clusters of lobular measures highly
correlated with each other. PCA outcomes were used for between group comparisons
and correlation analyses with neuropsychological and clinical features.
Results: Disease severity measured with ALS functional rating scale and index of
disease progression rate significantly correlated with CV reduction of the second PCA
cluster loading CV measures of anterior lobules. In all patients, cognitive impairment,
measured with verbal fluency, was related to CV reduction of the third cluster comprising
posterior lobules. No specific cortical thinning or volume reduction of cerebellar
clustering patterns could be detected in ALS subgroups.
Conclusion: Our data show that specific patterns of subregional cerebellar involvement
are associated with physical disability or cognitive impairment in ALS, in line with the
topographic organization of the cerebellum. However, there was no specific correlation
between cerebellar degeneration and cognitive syndromes or C9orf72 mutations.
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INTRODUCTION
The human cerebellum has been long recognized as playing
an essential role in motor control and coordination and it has
also become increasingly aligned with cognitive and affective
processing (Schmahmann and Sherman, 1998; Buckner, 2013).
Functional neuroimaging and connectivity studies in healthy
humans suggest a topographic organization in the cerebellum:
sensorimotor functions are represented in anterior lobules
I–V and inferior lobule VIII, while cognitive processing is
supported by posterior lobules (Stoodley and Schmahmann,
2009). Cerebellar abnormalities have been found not only in
primary cerebellar injury or degeneration, but also in many
psychiatric and neurological diseases without ataxia, including
Amyotrophic Lateral Sclerosis (ALS) (Gellersen et al., 2017;
Carass et al., 2018).
ALS is a fatal multisystemic neurodegenerative disorder
mainly characterized by progressive loss of upper and lower
motor neurons with cognitive and/or behavioral disturbance in
at least half of cases. ALS-associated cognitive syndrome includes
impairment of executive function, often with perseveration,
distractibility or inattention, language deficit and social cognition
impairment (Strong et al., 2017). Personality change might
also occur with apathy, blunting of affect or disinhibited and
inappropriate behavior (Strong et al., 2017). In a subset (15%)
of patients these cognitive and neuropsychiatric changes are
severe enough to fulfill criteria for the behavioral variant of
frontotemporal dementia (bvFTD) (Phukan et al., 2012). ALS
patients with the C9orf72 hexanucleotide repeat expansion
(C9+ALS) had significantly more co-morbid bvFTD features
than those without (Byrne et al., 2012). Cognitive and
neuropsychiatric features of ALS have largely been attributed
to changes in the frontotemporal and insular cortex (Tsujimoto
et al., 2011; Agosta et al., 2016; Westeneng et al., 2016;
Consonni et al., 2018a,b; Christidi et al., 2018a), although
increasing evidence suggest hippocampus and subcortical region
degeneration also plays a role (Bede et al., 2013b; Machts et al.,
2015; Westeneng et al., 2016), especially in C9+ALS patients
(Bede et al., 2013a; Agosta et al., 2017; Floeter et al., 2018;
Floeter and Gendron, 2018).
Evidence of cerebellar involvement in ALS is less commonly
reported (Prell and Grosskreutz, 2013). Structural changes
of the cerebellum in ALS have been described as regional
white matter changes (Bede et al., 2015) and decrease
gray matter volume (Thivard et al., 2007; Gellersen et al.,
2017; Christidi et al., 2018a,b). Cerebellar changes in ALS
and FTD have been specifically linked to the C9orf72
repeat expansion (Mackenzie et al., 2013), raising the
question whether cerebellar degeneration is an important
feature of C9+ALS.
In order to explore the relationship between cerebellar
involvement, cognitive impairment and C9orf72 repeated
expansion of patients with ALS, quantitative in vivo
assessment of cerebellar lobules has been investigated in a
large sample of non-demented ALS patients stratified on
the basis of cognitive and/or behavioral involvement and
C9orf72 mutation.
MATERIALS AND METHODS
Participants
Sixty-six non-demented patients diagnosed with probable or
definite ALS, according to El Escorial revised criteria (Brooks
et al., 2000) and 28 healthy control (HC) volunteers were included
in the study. Exclusion criteria were comorbid frontotemporal
dementia (Rascovsky et al., 2011), Alzheimer’s disease (NIA-AA),
evidence of another neurologic condition affecting cognition
(e.g., head trauma, hydrocephalus, and vascular disease), drug or
alcohol abuse, mental retardation, primary psychiatric disorders,
and other severe medical conditions. The review board of the
Fondazione IRCCS Istituto Neurologico Carlo Besta of Milan
approved the study. Each subject was enrolled after giving written
informed consent.
ALS Subgroups
Patients were assigned to subgroups on the basis of the
genetic screening for C9orf72 mutations and on the basis of
the presence of cognitive (ALSci) and/or behavioral (ALSbi)
impairment as defined by recent guidelines (Strong et al., 2017).
Accordingly, a cognitive screening protocol was administer to
all participants (Consonni et al., 2016; Table 1). Our cohort
was composed of 13 patients with a pathological C9orf72
expansion (C9+ALS) and 53 non-affected C9orf72 patients
(C9-ALS). Among C9-ALS patients, 31 patients had normal
cognitive profile (C9-ALScn) and 22 had ALSci and/or
ALSbi (C9-ALSimp).
Magnetic Resonance Imaging
All patients and healthy participants underwent a magnetic
resonance imaging (MRI) session within a week of
neuropsychological assessment, on a Philips Achieva 3.0
T. The MRI protocol included a 3D T1-weighted sequence
(FFE, 240 sagittal slices, TR = 9.9 ms, TE = 4.6 ms, matrix
240 × 240, voxel size = 1 × 1 × 1 mm3, and flip angle = 8). In
order to have a quantitative evaluation of cerebellum lobules
representing the current state of the art, we used the CERES
automated cerebellum parcellation algorithm (Romero et al.,
2017). With this tool, the MRI images are denoised, corrected for
inhomogeneity, rigid-body registered to Montreal Neurological
Institute (MNI) template, cropped around the cerebellum
area, and normalized to the MNI cropped cerebellum atlas.
An automatic multi-atlas patch-based segmentation was then
applied to obtain cerebellar cortical thickness (CT) and volume
(CV), expressed in percentage of total intracranial volume, for
each lobule (Manjón and Coupe, 2016).
Cerebellar Cluster Identification
CT and CV measures over twelve cerebellar lobules were
obtained. Principal Component Analysis (PCA) was then applied
as an unbiased method to reduce the number of variables for
subsequent between-group and correlation analyses. PCA with
oblimin rotation was used to identify the clustering pattern (of
highly correlated variables) of cerebellar CT and CV measures
of all subjects. For this purpose, for each CT and CV measure,
z-scores were calculated by subtracting the mean CT and CV of
Frontiers in Neuroscience | www.frontiersin.org 2 May 2019 | Volume 13 | Article 440
fnins-13-00440 May 10, 2019 Time: 16:37 # 3
Consonni et al. Cerebellar Cortical Integrity in ALS
TABLE 1 | Demographic, clinical and neuropsychological data (mean ± standard deviation).
C9-ALScn N = 31 C9-ALSimp N = 22 C9+ALS N = 13 HC N = 28 Group comparisons
Demographic data
Age (yrs.) 58.22 ± 9.4 60.81 ± 11.7 57.76 ± 8.5 57.28 l’ 10.1 n.s.
Education (yrs.) 11.29 ± 3.8 11.45 ± 4.1 8.53 ± 3.2 11.82 l’ 3.7 C9+ALS < HC∗
Male / Female 16 / 15 11 / 11 4 / 9 12 / 16 n.s.
Handedness (EHI) 21.60 ± 3.9 20.00 ± 6.13 21.33 ± 6.1 22.04 l’ 1.8 n.s.
Clinical data
ALSFRS-R 39.22 ± 5.6 37.95 ± 7.6 39.00 ± 6.09 – n.s.
Disease duration (mos.) 16.81 ± 12.0 18.77 ± 13.5 13.15 ± 7.3 – n.s.
Progression rate index 0.65 ± 0.4 0.63 ± 0.4 0.91 ± 0.8 – n.s.
Bulbar onset (yes / no) 3 / 28 7 / 15 3 / 10 – n.s.
Neuropsychological data
ALSci / ALSbi / ALScbi 0 / 0 / 0 17 / 1 / 4 8 / 2 / 0 – C9+ALS > C9–ALS∗
Phonemic fluency index 4.83 ± 1.9 6.90 ± 4.16 8.25 ± 7.9 4.17 l’ 2.0 C9-ALSimp > HC∗
Object naming (% correct) 95.72 ± 3.8 86.34 ± 10.2 89.09 ± 13.1 94.76 l’ 4.9 C9-ALSimp < HC∗∗∗ C9-ALSimp < C9-ALScn∗∗∗
Emotion attribution (SET) 4.89 ± 1.2 3.38 ± 1.56 3.36 ± 2.0 4.89 l’ 1.1 C9-ALSimp < HC∗∗ C9-ALSimp < C9-ALScn∗∗
Stroop effect 19.02 ± 8.1 31.31 ± 24.1 25.08 ± 9.3 20.25 l’ 7.9 C9-ALSimp < C9-ALScn∗
Delayed recall RAVLT 10.00 ± 2.5 7.62 ± 2.7 7.72 ± 3.28 10.36 l’ 2.6 C9-ALSimp < HC∗∗ C9-ALSimp < C9-ALScn∗∗
FBI tot 1.96 ± 2.5 4.00 ± 6.7 2.03 ± 3.4 – n.s.
ALSbi, ALS patients fulfilling Strong criteria for behavioral impairment; ALSci, ALS patients fulfilling Strong criteria for cognitive impairment; ALScbi, ALS patients fulfilling
criteria for ALSci and ALSbi; ALSFRS-R, Revised ALS Functional Rating Scale; FBI, Frontal Behavioral Inventory; RAVLT, Rey Auditory Verbal Learning Test; SET, Story-
based Empathy Task; and ns, not significant difference (p > 0.05). ∗∗∗p < 0.001; ∗∗p < 0.005; ∗p < 0.05.
TABLE 2 | Pattern matrix of PCA results for cerebellar lobar values of Cortical
Thickness (CT) of 94 subjects [66 patients with ALS and 24 healthy
controls (HCs)].
Rotated cluster loadings
Cluster 1 Cluster 2 Cluster 3 Cluster 4 KMO value
CTz Lobule IX 0.882 0.100 −0.165 0.181 0.752
CTz Lobule VIIIB 0.854 0.210 −0.246 0.398 0.746
CTz Lobule VIIIA 0.704 0.672 −0.120 0.220 0.725
CTz Lobule VIIB 0.255 0.894 0.004 −0.049 0.595
CTz Lobule CRUSII 0.053 0.840 −0.472 0.003 0.645
CTz Lobule VI 0.113 0.112 −0.858 0.144 0.822
CTz Lobule CRUS I 0.050 0.404 −0.830 0.048 0.693
CTz Lobule V 0.509 −0.160 −0.767 0.373 0.763
CTz Lobule IV 0.472 −0.184 −0.745 0.490 0.728
CTz Lobule I&II 0.221 −0.083 −0.114 0.882 0.685
CTz Lobule III 0.130 −0.195 −0.213 0.861 0.612
CTz Lobule X 0.247 0.138 −0.110 0.454 0.700
Eigenvalues 3.929 2.295 1.757 1.122
% of variance 32.74 19.13 14.64 9.35
The loading values in bold indicate the elements that contribute the greatest
variability to PCA clusters. ALScn, ALS patients with a cognitive and behavioral
normal profile; ALSimp, ALS patients fulfilling Strong criteria for behavioral and/or
cognitive impairment; C9+ALS, ALS patients with C9orf72 repeat expansions; and
HC, Healthy Controls.
HC subjects from the patient’s CT and CV, and then dividing
the difference by the HC group standard deviation. All variables
were normally distributed and had Kaiser-Meyer-Olkin (KMO)
values higher than 0.5. Clusters with eigenvalues over the Kaiser
criterion of one were retained. Cluster scores were calculated with
the Anderson-Rubin method and used for between group and
correlation analyses (Field, 2013).
Statistics
The Kolmogorov–Smirnov test was used to test the normality
of the distribution of demographic, clinical, neuropsychological
and neuroimaging data. Fisher Exact test, Kruskal–Wallis and
Mann–Whitney U tests were used to test between group
differences (i.e., C9-ALSimp, C9-ALScn, C9+ALS, and HC).
The variability of cerebellar cluster loadings of groups was
analyzed by ANCOVA, with age as covariates. Simple contrasts
were then used to test specific group comparisons. Partial
correlation analyses (correcting for age and education) were
used to explore the relationship of cerebellar cluster scores
with neuropsychological and clinical profiles in all patients as a
whole group. Significant correlations were then bias corrected
and accelerated bootstrap 95% confidence intervals (CIs) were
computed with 1000 bootstrap equally sized samples obtained by
randomly resampling replacement from the original data. Partial
correlations with p< 0.05 and CIs not crossing “0” were reported.
IBM SPSS Statistics (version 21) was used to perform analyses.
RESULTS
Clinical, Demographic and
Neuropsychological Data
Descriptive statistics are summarized in Table 1. C9-ALScn, C9-
ALSimp, C9+ALS, and HC groups did not differ in to age,
handedness, gender, but education (H = 9.019, p = 0.029). The
C9+ALS group had a slightly lower education level than the
HC group (U = 93.0, p = 0.012). Disease duration, functional
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disability assessed with the ALSFRS-R, progression and type
of onset were similar across ALS subgroups. HC and C9-
ALScn groups had similar neuropsychological performances.
The occurrence of cognitive and/or behavioral impairment is
higher for C9+ALS patients than C9-ALS patients (77% vs.
41%; p = 0.031). The C9-ALSimp group compared with HC
and C9-ALScn groups had lower performances in all cognitive
domains (Table 1).
Cerebellar Clustering Patterns
CTz. The KMO measure tested the sample adequacy of 12
cerebellar lobular CTz values for PCA (KMO = 0.708). The
rotation converged on 23 iterations. Four clusters had eigenvalues
over Kaiser criterion of one and in combination explained 78.41%
TABLE 3 | Pattern matrix of PCA results for cerebellar lobar values of Cortical
Volumes (CV) of 94 subjects (66 patients with ALS and 24 HCs).
Rotated cluster loadings
Cluster 1 Cluster 2 Cluster 3 Cluster 4 KMO value
CVz Lobule IX 0.826 −0.079 0.283 0.155 0.661
CVz Lobule VIIIB 0.727 0.391 0.153 0.108 0.690
CVz Lobule X 0.651 −0.054 0.324 0.494 0.779
CVz Lobule III −0.035 0.788 0.264 0.040 0.655
CVz Lobule V 0.201 0.684 0.126 0.506 0.685
CVz Lobule I&II 0.057 0.602 0.002 −0.014 0.528
CVz Lobule IV 0.487 0.498 0.119 0.364 0.702
CVz Lobule CRUSII 0.298 0.066 0.831 −0.016 0.609
CVz Lobule VIIB −0.092 0.130 0.773 0.284 0.668
CVz Lobule VIIIA 0.351 0.119 0.692 0.115 0.702
CVz Lobule VI 0.006 0.255 0.174 0.809 0.601
CVz Lobule CRUS I 0.339 −0.095 0.070 0.697 0.677
Eigenvalues 3.226 1.653 1.408 1.166
% of variance 26.88 13.77 11.73 9.71
The loading values in bold indicate the elements that contribute the greatest
variability to PCA clusters. ALScn, ALS patients with a cognitive and behavioral
normal profile; ALSimp, ALS patients fulfilling Strong criteria for behavioral and/or
cognitive impairment; C9+ALS, ALS patients with C9orf72 repeat expansions; and
HC, Healthy Controls.
of the variance (Table 2). Cluster 1 included CTz values of lobule
VIIIA, VIIIB, and IX; Cluster 2 included CTz values of Crus II
and VIIB, Cluster 3 loadings were CTz values of lobule IV, V, VI,
and Crus I; cluster 4 included lobule I&II and III and X.
CVz. The KMO measure tested the sample adequacy of 12
cerebellar lobular CV for PCA (KMO = 0.671). The rotation
converged on 10 iterations. Four clusters had eigenvalues over
Kaiser criterion of one and in combination explained 62.13% of
the variance (Table 3). Cluster 1 included CVz of lobule VIIIB,
IX, and X; Cluster 2 included CVz of anterior lobules (I&II, III,
IV, and V); Cluster 3 loadings were CVz values of CrusII, VIIB
and VIIIA; cluster 4 included CVz of lobule VI and Crus I.
We did not find group differences in cluster scores of CTz
and CVz measures (Table 4). Correlation analyses revealed that
only CVz scores of the second and third cluster were related to
functional disability measured with the ALSFRS-R in all patients
(r = 0.283, p = 0.024, CIs: 0.043–0.468; r = 0.281, p = 0.026,
CIs: 0.053–0.467). Cluster 2 CVz scores were also related to the
progression rate (r = −0.248, p = 0.050, CIs: −0.087 – −0.403).
Cluster 4 CVz scores were inversely related to the phonemic
fluency index (r =−0.335, p = 0.010, CIs:−0.157 –−0.535).
DISCUSSION
We tested the relationship between cerebellar degeneration,
cognitive syndromes and C9orf72 mutation in ALS patients.
The notion that cerebellum contributes to non-motor disorders,
such as impairments in language, attention and social cognition
is well recognized (Buckner, 2013). Consistently, we performed
a quantitative in vivo assessment of cerebellar lobular CT and
CV in a large sample of non-demented ALS patients stratified
on the basis of cognitive and/or behavioral impairment and
C9orf72 repeat expansion. To this aim, we used an unbiased
reduction method, the PCA, which allows projecting data into
a lower-dimensional space thus reducing the type I error and
identifying clusters of highly correlated variables with each other
(Field, 2013).
We identified 4 clusters of regional cerebellar CT and
demonstrated their scores were similar across ALS subgroups
TABLE 4 | Clustering pattern of cerebellar lobules (mean cluster score ± standard deviation).
ALScn N = 31 ALSimp N = 22 C9+ALS N = 13 HC N = 28 Group comparisons
Cortical thickness –
cluster scores
1. Lobule VIIIA, VIIIB, IX −0.278 ± 0.96 0.362 ± 0.75 −0.253 ± 1.27 0.141 ± 0.99 n.s.
2. Lobule Crus II, VIIB −0.004 ± 1.14 0.076 ± 0.82 −0.531 ± 1.16 0.191 ± 0.83 n.s.
3. Lobule IV, V, VI, Crus I −0.272 ± 0.89 −0.063 ± 0.80 0.463 ± 1.43 0.136 ± 0.95 n.s.
4. Lobule I&II, III, X −0.122 ± 1.07 0.353 ± 0.88 0.125 ± 0.99 −0.200 ± 0.96 n.s.
Cortical volumes – cluster
scores
1. Lobule VIIIB, IX, X 0.038 ± 0.86 −0.191 ± 0.94 0.263 ± 1.44 −0.014 ± 0.95 n.s.
2. Lobule I&II, III, IV, V 0.064 ± 0.97 −0.086 ± 1.29 −0.014 ± 1.11 0.003 ± 0.72 n.s.
3. Lobule Crus II, VIIB, VIIIA −0.042 ± 0.96 −0.323 ± 1.03 0.004 ± 0.99 0.299 ± 0.98 n.s.
4. Lobule VI, Crus I 0.201 ± 0.92 −0.306 ± 0.80 0.006 ± 0.87 0.014 ± 1.23 n.s.
n.s., not significant differences (p > 0.05).
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and HC individuals. Moreover, the lack of significant correlations
between cerebellar CT values, neuropsychological performances
and clinical features in patients suggests that the cerebellar
cortical thinning has a poor sensibility to detect cognitive
impairment in ALS. Cognitive and neuropsychiatric features
of ALS seem to be associated instead with thinning in
frontotemporal and insular cortex (Schuster et al., 2014; Agosta
et al., 2016; Consonni et al., 2018a,b).
By means of lobar CV measures, we identified four clustering
patterns. The clustering of the cerebellum respected lobular
anatomical boundaries and functional organization. Cluster 1
included posterior regions (VIIIB-IX, X), cluster 2 the sensory-
motor anterior regions (I-V), cluster 3 (CrusII-VIIIA), and 4
(VI-CrusI) included mainly cognitive posterior lobules. Contrary
to our expectation, no significant group differences in cluster
scores were found, but, as explorative analysis, a weak but
significant correlation between CV measures of the fourth cluster
and phonemic fluency indexes of ALS patients. Verbal fluency
is a widely recognized marker of dysexecutive impairment in
ALS (Strong et al., 2017). Specifically, poor verbal fluency was
related to reduced CV of lobule VI and CrusI. This is consistent
with previous studies documenting that lobules VI and Crus I
are involved in executive functions, such as working memory,
planning, organizing, and strategy formation (Stoodley and
Schmahmann, 2009). According to a meta-analysis of voxel-
based morphometry in cerebellum (Gellersen et al., 2017), the
largest cluster of gray matter reduction in ALS spanned parts of
the vermis and neighboring regions in left lobule VI, Crus I, and
Crus II. This suggests that cerebellar involvement in ALS may be
related to progressive cognitive impairment. However, as in other
studies (Schönecker et al., 2018), we did not find differences in
cerebellar volume within ALS cognitive subgroups, albeit specific
patterns of cerebellum atrophy in ALS-FTD patients have been
previously reported (Tan et al., 2014; Omer et al., 2017; Christidi
et al., 2018a,b). We could not exclude that discrepancies between
our findings and those reported by others are attributed to
differences in sample sizes and patients’ clinical features, as well as
different methodological (e.g., Surface-Based Analysis vs. Voxel-
Based Morphometry) and statistical approach and whether the
whole cerebellum or focal cerebellar regions were addressed.
We also found that severe motor disability and high rate
of disease progression were slightly related to CV reduction
of the sensory-motor cerebellar lobules. This is consistent with
the evidence of gradually progressive cerebellar gray matter
degeneration throughout disease progression in ALS (Bede and
Hardiman, 2017). A recent study showed reduced gray matter
volume (lobule IV and V) in ALS patients with no cognitive
defect and posterior (VIII) cerebellar involvement in ALS
patients with cognitive impairment (Christidi et al., 2018a). This
is in line with our correlation analyses, confirming that specific
patterns of subregional involvement are differently associated
with cognitive and motor impairment in ALS (Tan et al., 2014).
Unexpectedly, our investigation of the cerebellar subregions
did not revealed atrophy clusters specific for C9+ALS
patients, which is consistent with recent findings (Floeter
et al., 2016; Schönecker et al., 2018) but not with others
(Westeneng et al., 2016; Agosta et al., 2017). Since cerebellar
involvement in C9orf72 carriers have been found among
FTD-ALS spectrum (Bede et al., 2013a; Irwin et al., 2013; Floeter
et al., 2016), it is conceivable that it may reflect a signature of ALS
dementia other than a signature of the C9orf72 hexanucleotide
repeat (Bede et al., 2013a). Further studies deserve larger
C9+ALS samples stratified on the basis of the degree of cognitive
impairment to address this issue.
The strength of the presented study was the tentative to
systematically explore the cognitive contributions of cerebellar
atrophy in selected cohorts of patients with ALS. Our data
show that cerebellar degeneration is not specific for non-
demented patients with ALS and cognitive syndromes or
C9orf72 mutations. However, the relatively small number of
mutation carriers and the lack of ALS-FTD patients included
limit the strength for firm conclusion. Indeed, we could
not exclude that overall disease progression both in terms
of progressive physical disability and progressive cognitive
impairment might be related to cerebellar involvement, in line
with its topographic organization.
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